Receptor radionuclide therapy with 177Lu-DOTATATE in neuroendocrine tumours

被引：0
|
作者：
Bodei, L. [1 ]
Cremonesi, M. [1 ]
Grana, C. [1 ]
Bartolomei, M. [1 ]
Baio, S. [1 ]
Bufi, G. [1 ]
Fiorenza, M. [1 ]
Obenaus, E. [1 ]
Paganelli, G. [1 ]
机构：
[1] European Inst Oncol, Milan, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2006年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S214 / S214
页数：1
相关论文
共 50 条
  • [31] 177Lu-Dotatate Therapy for the treatment of metastatic neuroendocrine tumours in a patient on haemodialysis - Case report
    Kalogianni, E.
    Ruiz, D.
    Chakravartty, R.
    Corcoran, B.
    Devlin, L.
    Mulholland, N.
    Vivian, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S531 - S531
  • [32] Clinical Response Profile of Metastatic/Advanced Pulmonary Neuroendocrine Tumors to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE
    Parghane, Rahul V.
    Talole, Sanjay
    Prabhash, Kumar
    Basu, Sandip
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (06) : 428 - 435
  • [33] Management of a Patient With Metastatic Gastrointestinal Neuroendocrine Tumor and Meningioma Submitted to Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE
    Pirisino, Riccardo
    Filippi, Luca
    D'Agostini, Antonio
    Bagni, Oreste
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (11) : E692 - E695
  • [34] 177Lu-Dotatate for Midgut Neuroendocrine Tumors
    Hofman, Michael S.
    Michael, Michael
    Hicks, Rodney J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (14): : 1390 - 1391
  • [35] Large cardiac metastasis from pancreatic neuroendocrine tumor and response to peptide receptor radionuclide therapy with 177Lu-DOTATATE
    Rahul V. Parghane
    Sandip Basu
    Journal of Nuclear Cardiology, 2020, 27 : 340 - 341
  • [36] Evaluation of Kidney Dose in Neuroendocrine Tumors Patients after Peptide Receptor Radionuclide Therapy using 177Lu-DOTATATE
    Hidayati, N. R.
    Poon, A.
    Willowson, K.
    Eslick, E.
    Ryu, H.
    Bailey, D. L.
    ATOM INDONESIA, 2019, 45 (03) : 147 - 152
  • [37] 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors: Review of Treatment Workflow and Challenging Clinical Scenarios
    Abiodun-Ojo, Olayinka
    Shin, Muheon
    Chopra, Jigyasa
    Muzahir, Saima
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [38] Large cardiac metastasis from pancreatic neuroendocrine tumor and response to peptide receptor radionuclide therapy with 177Lu-DOTATATE
    Parghane, Rahul V.
    Basu, Sandip
    JOURNAL OF NUCLEAR CARDIOLOGY, 2020, 27 (01) : 340 - 341
  • [39] Data collection procedures for bone marrow dosimetry in peptide receptor radionuclide therapy with 177Lu-DOTATATE on neuroendocrine tumors
    Frederiksen, M. H. B.
    Klausen, T. L.
    de Nijs, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S631 - S631
  • [40] Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
    Sundlov, Anna
    Sjogreen-Gleisner, Katarina
    Svensson, Johanna
    Ljungberg, Michael
    Olsson, Tomas
    Bernhardt, Peter
    Tennvall, Jan
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (09) : 1480 - 1489
12345